I.ak
I - Interstitial/parenchymal lung disease
Shrinking lung syndrome
Last update 17/06/2026
May be difficult to separate from IXa. See also under Xd
Back
The Drug-Induced Respiratory Disease Website and App
Causative drugs
3
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
I.a
I.b
I.c
I.d
I.e
I.f
I.g
I.v
I.w
I.x
I.z
I.ab
I.ae
I.ak
I.ay
XLI.b
XLI.e
XLII.m
XLIII.a
XLIII.d
XLIII.t
XLIII.x
XLIII.af
XLIII.ag
XLIV.g
XLV.a
XLV.i
XLV.t
XLVI.a
XLVI.b
XLVII.a
XLVIII.a
XLVIII.d
XLVIII.r
XLVIII.ab
XLVIII.ac
XLIX.a
XLIX.c
XLIX.d
XLIX.e
XLIX.f
XLIX.i
XLIX.j
XLIX.l
XLIX.m
XLIX.o
XLIX.p
XLIX.u
XLIX.w
XLIX.ao
XLIX.ap
XLIX.ax
XLIX.az
XLIX.bj
L.l
L.v
L.ad
L.ar
L.as
L.av
LI.a
LI.c
LI.d
LI.f
LI.h
LI.n
LI.o
LI.s
LI.t
LI.ak
LI.az
LI.bd
LV.k
LV.v
LV.w
LV.bj
LV.bk
LV.bv
LVII.a
LVII.b
LVII.c
LVIII.a
LVIII.b
LVIII.d
LVIII.e
LVIII.f
LVIII.j
LVIII.o
LVIII.x
LVIII.ae
LVIII.al
LVIII.bx
LVIII.co
LVIII.cr
LVIII.cv
LIX.b
LIX.c
LIX.e
LIX.g
LIX.q
LIX.r
I.a
I.b
I.c
I.d
I.e
I.f
I.i
I.ae
I.ak
XLI.b
XLI.e
XLII.g
XLII.j
XLII.m
XLIII.a
XLIII.d
XLIII.t
XLIII.w
XLIII.x
XLIII.af
XLIII.ag
XLIV.g
XLIV.au
XLV.a
XLV.m
XLVI.b
XLVIII.a
XLVIII.d
XLVIII.h
XLVIII.r
XLVIII.y
XLVIII.ab
XLIX.a
XLIX.d
XLIX.f
XLIX.i
XLIX.l
XLIX.m
XLIX.o
XLIX.p
XLIX.u
XLIX.w
XLIX.ae
XLIX.az
L.as
L.bi
LI.c
LI.d
LI.h
LI.o
LI.t
LI.ak
LI.az
LII.c
LII.d
LV.i
LV.v
LV.w
LV.ac
LV.ad
LV.ak
LVII.a
LVII.b
LVII.c
LVIII.d
LVIII.e
LVIII.r
LVIII.al
LVIII.am
LVIII.au
LIX.a
LIX.c
LIX.g
LIX.ai